×
About 390 results

ALLMedicine™ Acalculous Cholecystitis Center

Research & Reviews  141 results

Safe and effective short-time percutaneous cholecystostomy: A retrospective observation...
https://doi.org/10.1097/MD.0000000000031412
Medicine Šimunić M, Cambj Sapunar L et. al.

Nov 8th, 2022 - The introduction of percutaneous cholecystostomy (PCT) has shifted the paradigm in treatment of acute calculous and acalculous cholecystitis. PCT has high success and low complication rates, but there are still unresolved issues regarding the dura...

Cyclophilin D regulates oxidative stress and apoptosis via mitochondrial permeability t...
https://doi.org/10.2174/1566524023666220908112922
Current Molecular Medicine; Hong K, Yang Q et. al.

Sep 13th, 2022 - Acute acalculous cholecystitis (AAC) is characterized by acute onset, rapid progression, high mortality, and various complications. Cyclophilin D (CypD) regulates the mitochondrial permeability transition pore (MPTP) and is involved in the occurre...

Extrapulmonary Manifestations of SARS-CoV-2: A Report of 3 Cases and a Literature Review.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375514
Annals of Transplantation; Barbachowska A, Gozdowska J et. al.

Aug 10th, 2022 - BACKGROUND COVID-19 disease, caused by the SARS-CoV-2 virus, has been one of the greatest challenges in modern medicine. It is mostly known to affect the pulmonary system, leading to pneumonia and acute respiratory distress syndrome, but there is ...

Acute Cholecystitis Clinical Presentation
http://emedicine.medscape.com/article/171886-clinical

Jul 13th, 2022 - History The most common presenting symptom of acute cholecystitis is upper abdominal pain. In some patients, the pain may radiate to the right shoulder or scapula. Frequently, the pain begins in the epigastric region and then localizes to the righ...

Acute Cholecystitis
https://emedicine.medscape.com/article/171886-overview

Jul 13th, 2022 - Practice Essentials Cholecystitis is inflammation of the gallbladder that occurs most commonly because of the presence of stones in the gallbladder or an obstruction of the cystic duct by gallstones arising from the gallbladder (cholelithiasis). U...

see more →

Guidelines  1 results

ACR Appropriateness Criteria® Right Upper Quadrant Pain.
https://doi.org/10.1016/j.jacr.2019.02.013
Journal of the American College of Radiology : JACR; , Peterson CM et. al.

May 6th, 2019 - Although right upper quadrant pain is a very common clinical presentation, it can be nonspecific. However, acute cholecystitis is very often the diagnosis of exclusion. This review focuses on the recommended imaging evaluation in the most commonly...

see more →

Clinicaltrials.gov  5 results

Endoscopic Ultrasonography (EUS) Guided Gallbladder Drainage With Two Months Stent Removal for Acute Cholecystitis: a Prospective Study
https://clinicaltrials.gov/ct2/show/NCT05272007

Apr 1st, 2022 - Acute cholecystitis (AC) is defined as an acute inflammatory disease of the gallbladder consequently to the presence of sludge or stones. AC accounts for 3-10% of all cases of abdominal pain. Cholecystolithiasis accounts for 90-95% of all causes o...

Complications in Acute Calculous Cholecystitis
https://clinicaltrials.gov/ct2/show/NCT05135299

Nov 26th, 2021 - Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments, the complication rate of ACC is 8-20%, and the mortality rate is 0.5-6% in recent series. The Tokyo Guidelines (TG) advocate for different...

The Incidence and Risk Factors of Biliary Complications in Patients With ECMO
https://clinicaltrials.gov/ct2/show/NCT04963322

Jul 15th, 2021 - Extracorporeal membrane oxygenation is an important method for the management of severe refractory heart and lung dysfunction, and improvements in extracorporeal membrane oxygenation equipment and increased experience have made it possible to use ...

Mortality Risk Estimation in Acute Calculous Cholecystitis: Beyond the Tokyo Guidelines
https://clinicaltrials.gov/ct2/show/NCT04744441

Feb 9th, 2021 - Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments, the complication rate of ACC is 20-55%, and the mortality rate is 0.5-15% in recent series. The Tokyo Guidelines (TG) advocate for differe...

The Influence of Ezetimibe on Gallbladder Function
https://clinicaltrials.gov/ct2/show/NCT00634140

Mar 30th, 2015 - Gallbladder disease continues to be a major healthcare problem in the United States with more than 750,000 cholecystectomies being performed each year. In the last decade, the proportion of elective cholecystectomies performed for chronic acalculo...

see more →

News  9 results

GI Issues in Kids With COVID-19 MIS-C May Muddy Diagnosis
https://www.medpagetoday.com/infectiousdisease/covid19/86972

Jun 9th, 2020 - Children and adolescents with COVID-19 who developed multisystem inflammatory syndrome (MIS-C) often exhibited marked gastrointestinal (GI) manifestations, sometimes confounding diagnosis by mimicking GI infections or inflammatory bowel disease (I...

New Serious Adverse Effects With Alemtuzumab in MS
https://www.medscape.com/viewarticle/895124

Apr 12th, 2018 - Several new and potentially life-threatening adverse events associated with the use of alemtuzumab (Lemtrada, Genzyme) in multiple sclerosis (MS) have been reported. Three separate papers published online in Neurology on March 30 describe eight ca...

Rare, serious alemtuzumab adverse events emerge
https://www.mdedge.com/multiplesclerosishub/article/163273/multiple-sclerosis/rare-serious-alemtuzumab-adverse-events
Jim Kling

Apr 11th, 2018 - Rare but serious adverse events associated with alemtuzumab treatment of multiple sclerosis (MS) have recently been revealed by postmarketing surveillance, according to three new case reports and series in Neurology. The complications include acut.

Rare, serious alemtuzumab adverse events emerge
https://www.mdedge.com/neurology/article/163273/multiple-sclerosis/rare-serious-alemtuzumab-adverse-events-emerge
Jim Kling

Apr 11th, 2018 - Rare but serious adverse events associated with alemtuzumab treatment of multiple sclerosis (MS) have recently been revealed by postmarketing surveillance, according to three new case reports and series in Neurology. The complications include acut.

More Risks Emerge for Alemtuzumab in MS
https://www.medpagetoday.com/neurology/multiplesclerosis/72194

Apr 6th, 2018 - Action Points Note that several case reports document severe side effects associated with alemtuzumab use in patients with relapsing-remitting multiple sclerosis. Acute acalculous cholecystitis has been previously reported and now appears on the p...

see more →